Many individuals notice a more even skin tone, a refreshed complexion, and an overall healthier glow over time
Doeppner TR, Kaltwasser B, Elali A, Zechariah A, Hermann DM, Bhr M
Introducing this effect gradually may help reduce the gastrointestinal side effects (such as nausea, vomiting, and diarrhea) that are most common when a dose is first increased
Los datos sobre la relacin entre el uso de los GLP-1 y el retardo en el vaciamiento gstrico son limitados
Retatrutide is an investigational triple agonist peptide that targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously